Review: Tissue remodeling and angiogenesis in asthma: The role of the eosinophil

Therapeutic Advances in Respiratory Disease

Volumn 2, Issue 3, 2008, Pages 163-171

  Nissim Ben Efraim, A H ^a   Levi Schaffer, F ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Angiogenesis; asthma; eosinophils; remodeling

Indexed keywords

AE 941; ANGIOSTATIN; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BEVACIZUMAB; BUDESONIDE; CHEMOKINE RECEPTOR CCR3; DEXAMETHASONE; ENDOSTATIN; EOSINOPHIL CHEMOTACTIC FACTOR; FIBROBLAST GROWTH FACTOR; FLUTICASONE; FUMAGILLIN; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARANASE; HYDROCORTISONE; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 8; INTERLEUKIN 9; MAJOR BASIC PROTEIN; MEPOLIZUMAB; RAPAMYCIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ALLERGIC REACTION; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ASTHMA; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MEGADOSE; DRUG TARGETING; ENZYME ACTIVITY; EOSINOPHIL; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; INFLAMMATION; INFLAMMATORY CELL; LUNG FIBROBLAST; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL; UPREGULATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ASTHMA; EOSINOPHILS; HUMANS; LUNG; NEOVASCULARIZATION, PATHOLOGIC;

EID: 67349278255     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465808092281     Document Type: Review

References (72)

1. Asai, K., Kanazawa, H., Kamoi, H., Shiraishi, S., Hirata, K. and Yoshikawa, J. (2003) Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 33(5): 595-599.
2. Asai, K., Kanazawa, H., Otani, K., Shiraishi, S., Hirata, K. and Yoshikawa, J. (2002) Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. J Allergy Clin Immunol 110(4): 571-575.
3. Asquith, K.L., Ramshaw, H.S., Hansbro, P.M., Beagley, K.W., Lopez, A.F. and Foster, P.S. (2008) The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation. J Immunol 180(2): 1199-1206.
4. Bandi, N. and Kompella, U.B. (2001) Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur J Pharmacol 425(2): 109-116.
5. Barnes, P.J. (1999) Effect of beta-agonists on inflammatory cells. J Allergy Clin Immunol 104(2): S10-S17.
6. Bochner, B.S. and Busse, W.W. (2005) Allergy and asthma. J Allergy Clin Immunol 115(5): 953-959.
7. Bussolino, F., Wang, M.J., Defilippi, P., Turrini, F., Sanavio, F., Edgell, C.J.S. et al. (1989) Granulocyte-and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337: 471-473.
8. Bussolino, F., Ziche, M., Wang, J.M., Alessi, D., Morbidelli, L., Cremona, O. et al. (1991) In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest 87(3): 986-995.
9. Cantarella, G., Lampereur, L., Presta, M., Ribatti, D., Lombardo, G., Lazarovici, P. (2002) Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 16(10): 1307-1309.
10. Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438(7070): 932-936.
11. Chetta, A., Zanini, A., Foresi, A., D'Ippolito, R., Tipa, A., Castagnaro, A. et al. (2005) Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. Clin Exp Allergy 35(11): 1437-1442.
12. Cho, J.Y., Miller, M., Baek, K.J., Han, J.W., Nayar, J., Lee, S.Y. et al. (2004) Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 113(4): 551-560.
13. Cohn, L., Elias, J.A. and Chupp, G.L. (2004) Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22: 789-815.
14. Coussens, L.M., Fingleton, B. and Matrisian, L.M. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295(5564): 2387-2392.
15. Cross, M.J. and Claesson-Welsh, L. (2001) FGF and VEGF function in angiogenesis: signaling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22(4): 201-207.
16. Doherty, T. and Broide, D. (2007) Cytokines and growth factors in airway remodeling in asthma. Curr Opin Immunol 19(6): 676-680.
17. Dunnill, M.S. (1960) The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol 13: 27-33.
18. Elovic, A., Wong, D., Weller, P., Matossian, K. and Galli, S. (1994) Expression of transforming growth factor-α and β messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 93(5): 864-869.
19. Ferrara, N., Hillan, K.J. and Novotny, W. (2005) Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 333(2): 328-335.
20. Flood-Page, P., Menzies-Gow, A., Phipps, S., Ying, S., Wangoo, A., Ludwig, M.S. et al. (2003) Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 112(7): 1029-1036.
21. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1(1): 27-31.
22. Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M. et al. (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8(2): 128-135.
23. Hickey, M.M. and Simon, M.C. (2006) Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol 76: 217-257.
24. Holgate, S.T. (2004) Cytokine and anti-cytokine therapy for the treatment of asthma and allergic disease. Cytokine 28(4-5): 152-157.
25. Homer, R.J. and Elias, J.A. (2005) Airway remodeling in asthma: therapeutic implications of mechanisms. Physiology (Bethesda) 20: 28-35.
26. Horiuchi, T. and Weller, P.F. (1997) Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 17(1): 70-77.
27. Hoshino, M., Takahashi, M. and Aoike, N. (2001) Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 107(2): 295-301.
28. Humbles, A.A., Lloyd, C.M., McMillan, S.J., Friend, D.S., Xanthou, G., McKenna, E.E. et al. (2004) A critical role for eosinophils in allergic airways remodeling. Science 305(5691): 1776-1779.
29. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H. et al. (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348(6301): 555-557.
30. James, A. (2005) Airway remodeling in asthma. Curr Opin Pulm Med 11(1): 1-6.
31. Kariyawasam, H.H. and Robinson, D.S. (2007) The role of eosinophils in airway tissue remodelling in asthma. Curr Opin Immunol 19(6): 681-686.
32. Kelly, E.A. and Jarjour, N.N. (2003) Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med 9(1): 28-33.
33. Lee, C.G., Link, H., Baluk, P., Homer, R.J., Chapoval, S., Bhandari, V. et al. (2004) Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10(10): 1095-1103.
34. Lee, S.Y., Paik, S.Y. and Chung, S.M. (2005) Neovastat (AE-941) inhibits the airway inflammation and hyperresponsiveness in a murine model of asthma. J Microbiol 43(1): 11-16.
35. Lee,Y.C., Kwak,Y.G. and Song, C.H. (2002) Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol 168(7): 3595-3600.
36. Levi-Schaffer, F., Garbuzenko, E., Rubin, A., Reich, R., Pickholz, D., Gillery, P. et al. (1999) Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta). Proc Natl Acad Sci USA 96(17): 9660-9665.
37. Li, A., Dubey, S., Varney, M.L., Dave, B.J. and Singh, R.K. (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170(6): 3369-3376.
38. Li, X. and Wilson, J.W. (1997) Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 156(1): 229-233.
39. Makinde, T., Murphy, R.F. and Agrawal, D.K. (2007) The regulatory role of TGF-beta in airway remodeling in asthma. Immunol Cell Biol 85(5): 348-356.
40. McDonald, D.M. (2001) Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 164(10 Pt 2): S39-S45.
41. Menzies-Gow, A., Flood-Page, P., Sehmi, R., Burman, J., Hamid, Q., Robinson, D.S. et al. (2003) Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 111(4): 714-719.
42. Munitz, A., Bachelet, I. and Levi-Schaffer, F. (2006) Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol 118(5): 1082-1089.
43. Nauck, M., Karakiulakis, G., Perruchoud, A.P., Papakonstantinou, E. and Roth, M. (1998) Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 341(2-3): 309-315.
44. Nomura, S., Kanazawa, H., Hirata, K., Iwao, H. and Yoshikawa, J. (2005) Relationship between vascular endothelial growth factor and angiopoietin-2 in asthmatics before and after inhaled beclomethasone therapy. J Asthma 42(2): 141-146.
45. Okada, S., Kita, H., George, T.J., Gleich, G.J. and Leiferman, K.M. (1997) Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 17(4): 519-528.
46. O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S. et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88(2): 277-285.
47. O'Reilly, M.S., Holmgren, L., Shing,Y., Chen, C., Rosenthal, R.A., Moses, M. et al. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79(2): 315-328.
48. Pégorier, S., Wagner, L.A., Gleich, G.J. and Pretolani, M. (2006) Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J Immunol 177: 4861-4869.
49. Phipps, S., Ying, S., Wangoo, A., Ong,Y.E., Levi-Schaffer, F. and Kay, A.B. (2002) The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol 169(8): 4604-4612.
50. Piliponsky, A.M., Gleich, G.J., Bar, I. and Levi-Schaffer, F. (2002) Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. Mol Immunol 38(16-18): 1369.
51. Piliponsky, A.M., Gleich, G.J., Nagler, A., Bar, I. and Levi-Schaffer, F. (2003) Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 101(5): 1898-1904.
52. Pugh, C.W. and Ratcliffe, P.J. (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9(6): 677-684.
53. Puxeddu, I., Berkman, N., Nissim Ben Efraim, A.H., Davies, D., Ribatti, D., Gleich, G.J. et al. (2008) The role of eosinophil major basic protein (MBP) in angiogenesis. Allergy (accepted).
54. Puxeddu, I., Alian, A., Piliponsky, A.M., Ribatti, D., Panet, A. and Levi-Schaffer, F. (2005a) Human peripheral blood eosinophils induce angiogenesis. Int J Biochem Cell Biol 37(3): 628-636.
55. Puxeddu, I., Ribatti, D., Crivellato, E. and Levi-Schaffer, F. (2005b) Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 116(3): 531-536.
56. Rochester, C.L., Ackerman, S.J., Zheng, T. and Elias, J.A. (1996) Eosinophil-fibroblast interaction. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol 156(11): 4449-4456.
57. Sabroe, I., Conroy, D.M., Gerard, N.P., Li, Y., Collins, P.D., Post, T.W. et al. (1998) Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo. J Immunol 161(11): 6139-6147.
58. Salcedo, R., Young, H.A., Ponce, M.L., Ward, J.M., Kleinman, H.K., Murphy, W.J. et al. (2002) Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells. J Immunol 166(12): 7571-7578.
59. Salvato, G. (2001) Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 56(12): 902-906.
60. Schuler, W., Sedrani, R., Cottens, S., Haberlin, B., Schulz, M., Schuurman, H.J. et al. (1997) SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Transplantation 64(1): 36-42.
61. Schwingshackl, A., Duszyk, M., Brown, N. and Moqbel, R. (1999) Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J Allergy Clin Immunol 104(5): 983-989.
62. Simcock, D.E., Kanabar, V., Clarke, G.W., O'Connor, B.J., Lee, T.H. and Hirst, S.J. (2007) Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. Am J Respir Crit Care Med 176(2): 146-153.
63. Solomon, A., Aloe, L., Pe'er, J. Frucht-Pery, J., Bonini, S., Bonini, S. et al. (1998) Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol 102(3): 454-460.
64. Temkin,V., Aingorn, H., Puxeddu, I., Goldshmidt, O., Zcharia, E., Gleich, G.J. et al. (2004) Eosinophil major basic protein: first identified natural heparanase-inhibiting protein. J Allergy Clin Immunol 113(4): 703-709.
65. Tomasek, J.J., Gabbiani, G., Hinz, B., Chaponnier, C. and Brown, R.A. (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3(5): 349-363.
66. Vignola, A.M. (2003) Effects of inhaled corticosteroids, leukotriene receptor antagonists, or both, plus long-acting beta2-agonists on asthma pathophysiology: a review of the evidence. Drugs 63 (Suppl 2): 35-51.
67. Vignola, A.M., Kips, J. and Bousquet, J. (2000) Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 105(6 Pt 1): 1041-1053.
68. Vignola, A.M., Mirabella, F., Costanzo, G., Di Giorgi, R., Gjomarkaj, M., Bellia, V. et al. (2003) Airway remodeling in asthma. Chest 123(Suppl 3): 417S-422S.
69. Ward, C. and Walters, H. (2005) Airway wall remodelling: the influence of corticosteroids. Curr Opin Allergy Clin Immunol 5(1): 43-48.
70. Wong, D.T., Elovic, A., Matossian, K., Nagura, N., McBride, J., Chou, M.Y. et al. (1991) Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood 78(10): 2702-2707.
71. Yousefi, S., Hemmann, S., Weber, M., Hölzer, C., Hartung, K., Blaser, K. et al. (1995) IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol 154(10): 5481-5490.
72. Zagai, U., Dadfar, E., Lundahl, J., Venge, P. and Skold, C.M. (2007) Eosinophil cationic protein stimulates TGF-beta1 release by human lung fibroblasts in vitro. Inflammation 30(5): 153-160.